BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29509268)

  • 21. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.
    Lee D; Lee KH; Park H; Kim SH; Jin T; Cho S; Chung JH; Lim S; Park S
    PLoS One; 2013; 8(8):e69669. PubMed ID: 23936343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice.
    Grootaert MOJ; Schrijvers DM; Van Spaendonk H; Breynaert A; Hermans N; Van Hoof VO; Takahashi N; Vandenabeele P; Kim SH; De Meyer GRY; Martinet W
    Atherosclerosis; 2016 Sep; 252():166-174. PubMed ID: 27425215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cell-mediated chronic low-grade inflammation is regulated by the RAGE-TLR4-PKCβ
    Zhao L; Li Y; Xu T; Lv Q; Bi X; Liu X; Fu G; Zou Y; Ge J; Chen Z; Zhang W
    Mol Med; 2022 Jan; 28(1):4. PubMed ID: 35062863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
    Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulatory role of HMG-CoA reductase inhibitors and ezetimibe on LDL-AGEs-induced ROS generation and RAGE-associated signalling in HEK-293 Cells.
    Nabi R; Alvi SS; Shah A; Chaturvedi CP; Iqbal D; Ahmad S; Khan MS
    Life Sci; 2019 Oct; 235():116823. PubMed ID: 31476307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes.
    Tam HL; Shiu SW; Wong Y; Chow WS; Betteridge DJ; Tan KC
    Atherosclerosis; 2010 Mar; 209(1):173-7. PubMed ID: 19733353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice.
    Dou L; Lu Y; Shen T; Huang X; Man Y; Wang S; Li J
    Cell Physiol Biochem; 2012; 29(5-6):875-82. PubMed ID: 22613987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NaoXinTong Enhances Atorvastatin-induced Plaque Stability While Ameliorating Atorvastatin-induced Hepatic Inflammation.
    Yang X; Li Y; Sun L; Liu Y; Ma C; Chen Y; Tan H; Li Q; Li X; Wang Y; Duan Y; Zhao B; Han J
    J Cardiovasc Pharmacol; 2017 Jan; 69(1):55-64. PubMed ID: 27828790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suxiaojiuxin pill enhances atherosclerotic plaque stability by modulating the MMPs/TIMPs balance in ApoE-deficient mice.
    Zhang J; Zhuang P; Lu Z; Zhang M; Zhang T; Zhang Y; Wang J; Liu D; Tong Y
    J Cardiovasc Pharmacol; 2014 Aug; 64(2):120-6. PubMed ID: 24621651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.
    Nie P; Li D; Hu L; Jin S; Yu Y; Cai Z; Shao Q; Shen J; Yi J; Xiao H; Shen L; He B
    PLoS One; 2014; 9(5):e97009. PubMed ID: 24816562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
    Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
    APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of EphA2 protects against atherosclerosis by synergizing with statins to mitigate macrophage inflammation.
    Zeng J; Wu Q; Xiong S; Lu C; Zhang Z; Huang H; Xiong Y; Luo T
    Biomed Pharmacother; 2023 Dec; 169():115885. PubMed ID: 37984301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.
    Souza AW; de Leeuw K; van Timmeren MM; Limburg PC; Stegeman CA; Bijl M; Westra J; Kallenberg CG
    PLoS One; 2014; 9(4):e96067. PubMed ID: 24776932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins Disrupt Macrophage Rac1 Regulation Leading to Increased Atherosclerotic Plaque Calcification.
    Healy A; Berus JM; Christensen JL; Lee C; Mantsounga C; Dong W; Watts JP; Assali M; Ceneri N; Nilson R; Neverson J; Wu WC; Choudhary G; Morrison AR
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):714-732. PubMed ID: 31996022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atorvastatin Upregulates the Expression of miR-126 in Apolipoprotein E-knockout Mice with Carotid Atherosclerotic Plaque.
    Pan X; Hou R; Ma A; Wang T; Wu M; Zhu X; Yang S; Xiao X
    Cell Mol Neurobiol; 2017 Jan; 37(1):29-36. PubMed ID: 26886754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of astragali radix extract on matrix metalloproteinase 9 expression and atherosclerotic plaque formation in aorta of apolipoprotein E deficient mice fed with high fat diet].
    You Y; Duan Y; Zhang XL; Kang J; Yan CH; Zhang XL; Feng JT; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):522-6. PubMed ID: 22943650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products.
    Feng B; Xu L; Wang H; Yan X; Xue J; Liu F; Hu JF
    Biochim Biophys Acta; 2011 Sep; 1812(9):1130-7. PubMed ID: 21651980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atorvastatin attenuates p‑cresyl sulfate‑induced atherogenesis and plaque instability in ApoE knockout mice.
    Han H; Chen Y; Zhu J; Ni J; Sun J; Zhang R
    Mol Med Rep; 2016 Oct; 14(4):3122-8. PubMed ID: 27574007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.